title: Amendments to sterility test requirements for biological products. Final rule.
abstract: The Food and Drug Administration (FDA) is amending the sterility test requirements for biological products. This rule provides manufacturers of biological products greater flexibility, as appropriate, and encourages use of the most appropriate and state-of-the-art test methods for assuring the safety of biological products. FDA is taking this action as part of its ongoing efforts to comprehensively review and, as necessary, revise its regulations related to biological products.
mesh_terms: D001688:Biological Products / Q000592:standards*; D002626:Chemistry, Pharmaceutical / Q000592:standards*; D046508:Culture Techniques / Q000592:standards; D004340:Drug Contamination; D006801:Humans; D008828:Microbiological Techniques / Q000592:standards*; D011786:Quality Control; D012449:Safety / Q000592:standards; D013242:Sterilization / Q000592:standards*; D014481:United States
chemical_list: D001688:Biological Products